INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

  • Ready For Remote: eCOA Adapts To A Hybrid World

    Due to the global health impact of COVID-19, many aspects of daily life have been moved to a hybrid model, meaning a mix of in-person and technology-enabled interactions In this blog, learn why eCOAs are especially well-suited for hybrid clinical trials.

  • 7 Considerations For eCOA Technology Solutions

    Choosing the right vendor, solution, and deployment model is critical for a clinical trial to be successful. As a sponsor, consider these seven best practices when selecting the best eCOA.

  • Designing ePRO and eConsent Solutions that Participants and Sites Want

    Participant-focused eClinical technologies offer significant potential to decrease paper-based processes and improve end-user experiences in collecting patient-reported outcomes (PRO) and informed consent, but many users continue to experience rigid technology, complicated hardware provisioning processes, and clunky implementations that leave sponsors, CROs and sites questioning the value. 

  • Considerations For Using RWD/RWE In Oncology Drug Approvals

    Delve into a collection of select case studies where various examples of RWD/RWE applications are analyzed for strengths and weaknesses as perceived by regulatory agencies, illustrating key insights with regard to study design.

CLINICAL TRIAL TECHNOLOGY SOLUTIONS